MariMed Q2 2026 revenue up 6% to $41.9M; net loss widens to $3.6M

MARIMED INC.

Revenue of $41.9M in Q2 2026, up 6% from $39.5M in Q2 2025; H1 revenue $81.4M vs $77.4M.
GAAP net loss widened to $3.6M in Q2 vs $1.4M a year ago; non-GAAP net loss $2.4M vs $0.3M profit.
Non-GAAP adjusted EBITDA fell to $3.9M (9% margin) from $4.8M (12% margin) in Q2 2025.
GAAP gross margin 39% vs 40%; non-GAAP gross margin 40% vs 42%, down YoY.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.